Publicacións en colaboración con investigadores/as de University of Sydney (16)

2024

  1. Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank

    Clinical and experimental rheumatology, Vol. 42, Núm. 2, pp. 277-287

2022

  1. An International Perspective on Preceding Infections in Guillain-Barré Syndrome: The IGOS-1000 Cohort

    Neurology, Vol. 99, Núm. 12, pp. E1299-E1313

  2. Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

    JHEP Reports, Vol. 4, Núm. 5

  3. Equity in vaccination policies to overcome social deprivation as a risk factor for invasive meningococcal disease

    Expert Review of Vaccines, Vol. 21, Núm. 5, pp. 659-674

  4. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Nature, Vol. 604, Núm. 7906, pp. 502-508

2021

  1. Development of a patient-centered core domain set for prospective observational longitudinal outcome studies in rheumatoid arthritis: an OMERACT initiative

    Seminars in Arthritis and Rheumatism, Vol. 51, Núm. 5, pp. 1113-1116

2017

  1. Evolocumab and clinical outcomes in patients with cardiovascular disease

    New England Journal of Medicine, Vol. 376, Núm. 18, pp. 1713-1722

2016

  1. Natural resistance to Meningococcal Disease related to CFH loci: Meta-analysis of genome-wide association studies

    Scientific Reports, Vol. 6

  2. The diagnosis and management of lipodystrophy syndromes: A multi-society practice guideline

    Journal of Clinical Endocrinology and Metabolism, Vol. 101, Núm. 12, pp. 4500-4511

2015

  1. Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1

    American Journal of Medical Genetics, Part A, Vol. 167, Núm. 2, pp. 296-312

2014

  1. The burden of disease in Spain: Results from the global burden of disease study 2010

    BMC Medicine, Vol. 12, Núm. 1

  2. The global burden of rheumatoid arthritis: Estimates from the Global Burden of Disease 2010 study

    Annals of the Rheumatic Diseases, Vol. 73, Núm. 7, pp. 1316-1322

2012

  1. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010

    The Lancet, Vol. 380, Núm. 9859, pp. 2197-2223

  2. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010

    The Lancet, Vol. 380, Núm. 9859, pp. 2163-2196

2010

  1. Rheumatoid arthritis

    Best Practice and Research: Clinical Rheumatology, Vol. 24, Núm. 6, pp. 733-745

2008

  1. Telmisartan, ramipril, or both in patients at high risk for vascular events

    New England Journal of Medicine, Vol. 358, Núm. 15, pp. 1547-1559